ANKRD2
Basic information
Region (hg38): 10:97572499-97583884
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANKRD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 19 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 19 | 2 | 1 |
Variants in ANKRD2
This is a list of pathogenic ClinVar variants found in the ANKRD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-97572621-TGGC-T | Benign (Dec 31, 2019) | |||
10-97572741-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
10-97572774-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
10-97572813-G-A | not specified | Uncertain significance (May 09, 2022) | ||
10-97572817-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
10-97572822-C-A | not specified | Uncertain significance (Dec 27, 2023) | ||
10-97572842-C-G | not specified | Uncertain significance (Mar 25, 2024) | ||
10-97577812-G-A | not specified | Uncertain significance (Jul 13, 2022) | ||
10-97577837-A-T | not specified | Uncertain significance (Jan 24, 2024) | ||
10-97578273-C-G | not specified | Uncertain significance (Mar 11, 2024) | ||
10-97578365-C-G | Likely benign (Aug 01, 2022) | |||
10-97578505-C-T | Benign/Likely benign (Aug 01, 2022) | |||
10-97578541-A-T | not specified | Uncertain significance (Jan 24, 2023) | ||
10-97578544-G-A | not specified | Uncertain significance (Nov 09, 2023) | ||
10-97578579-G-T | not specified | Uncertain significance (Dec 11, 2023) | ||
10-97580862-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
10-97581364-G-T | not specified | Uncertain significance (Aug 12, 2021) | ||
10-97582357-G-A | not specified | Uncertain significance (Apr 25, 2023) | ||
10-97582401-T-A | not specified | Uncertain significance (May 08, 2024) | ||
10-97583578-A-G | Benign (Aug 20, 2018) | |||
10-97583589-C-T | not specified | Uncertain significance (Mar 08, 2024) | ||
10-97583605-G-C | not specified | Uncertain significance (May 08, 2024) | ||
10-97583611-G-C | not specified | Uncertain significance (Jun 21, 2022) | ||
10-97583613-A-T | not specified | Uncertain significance (May 26, 2023) | ||
10-97583655-C-T | not specified | Uncertain significance (Apr 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ANKRD2 | protein_coding | protein_coding | ENST00000307518 | 9 | 11444 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.47e-8 | 0.381 | 125699 | 0 | 48 | 125747 | 0.000191 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.15 | 176 | 225 | 0.784 | 0.0000145 | 2291 |
Missense in Polyphen | 83 | 98.482 | 0.84279 | 905 | ||
Synonymous | 1.53 | 80 | 99.4 | 0.805 | 0.00000693 | 730 |
Loss of Function | 0.803 | 14 | 17.6 | 0.794 | 0.00000101 | 189 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00144 | 0.00142 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000117 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000830 | 0.0000791 |
Middle Eastern | 0.000117 | 0.000109 |
South Asian | 0.000163 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as a negative regulator of myocyte differentiation. May interact with both sarcoplasmic structural proteins and nuclear proteins to regulate gene expression during muscle development and in response to muscle stress. {ECO:0000269|PubMed:21737686, ECO:0000269|PubMed:22016770}.;
Recessive Scores
- pRec
- 0.131
Intolerance Scores
- loftool
- 0.928
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.22
Haploinsufficiency Scores
- pHI
- 0.314
- hipred
- N
- hipred_score
- 0.442
- ghis
- 0.471
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.765
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ankrd2
- Phenotype
- muscle phenotype; immune system phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of cytokine production;regulation of transcription by RNA polymerase II;muscle contraction;muscle organ development;skeletal muscle tissue development;negative regulation of myotube differentiation;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;negative regulation of myoblast differentiation;regulation of intrinsic apoptotic signaling pathway by p53 class mediator;regulation of myoblast proliferation
- Cellular component
- euchromatin;nucleus;cytosol;PML body;I band;intracellular membrane-bounded organelle
- Molecular function
- chromatin binding;structural constituent of muscle;titin binding;protein kinase B binding;RNA polymerase II-specific DNA-binding transcription factor binding